ACON Pharmaceuticals — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

ACON Pharmaceuticals is a private, US-based company specializing in advanced drug delivery systems and RNA therapeutics. It operates a hybrid business model combining proprietary technology platform development, internal pipeline programs, and a broad range of contract services for the biopharma industry. With deep expertise in lipid nanoparticles (LNP), liposomes, and other delivery technologies, ACON positions itself as an integrated partner for developing next-generation complex pharmaceuticals and 505(b)(2) products.

Drug DeliveryRNA & Gene Therapy

Technology Platform

Proprietary drug delivery platforms including Lipid Nanoparticles (LNP) for RNA delivery, liposomes, nanoparticles, nanocrystals, microspheres, nanoemulsions, micelles, resinates, oral dissolving films, and transdermal systems.

Opportunities

The company is well-positioned to capitalize on the explosive growth in RNA therapeutics and the increasing outsourcing of complex formulation work by biopharma companies.

Its diversified model, spanning CDMO services, chemical supply, and medical devices, provides multiple revenue streams and reduces reliance on any single pipeline asset.

Risk Factors

ACON faces intense competition from larger, well-funded CDMOs and drug delivery specialists.

Its internal therapeutic pipeline is at an early, high-risk stage, and the company's private status and limited public data make assessing its financial runway and scalability challenging.

Competitive Landscape

ACON competes in a crowded field of drug delivery specialists and CDMOs, including giants like Catalent and Lonza, as well as numerous niche platform companies (e.g., Arcturus, ReCode for LNP). Its differentiation lies in its broad technology portfolio, specific focus on RNA delivery, and integrated service offering from synthesis to formulation.

More companies in Drug Delivery & Formulation →More companies in United States →